[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1856090T3 - Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser - Google Patents

Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser

Info

Publication number
DK1856090T3
DK1856090T3 DK06720513T DK06720513T DK1856090T3 DK 1856090 T3 DK1856090 T3 DK 1856090T3 DK 06720513 T DK06720513 T DK 06720513T DK 06720513 T DK06720513 T DK 06720513T DK 1856090 T3 DK1856090 T3 DK 1856090T3
Authority
DK
Denmark
Prior art keywords
glucagon receptor
preparation
receptor antagonists
compounds
therapeutic applications
Prior art date
Application number
DK06720513T
Other languages
Danish (da)
English (en)
Inventor
Mark Donald Chappell
Scott Eugene Conner
Allie Edward Tripp
Guoxin Zhu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36694345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1856090(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1856090T3 publication Critical patent/DK1856090T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06720513T 2005-02-11 2006-02-09 Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser DK1856090T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65249205P 2005-02-11 2005-02-11
PCT/US2006/004461 WO2006086488A2 (fr) 2005-02-11 2006-02-09 Antagonistes du recepteur du glucagon, leur preparation et leurs utilisations therapeutiques

Publications (1)

Publication Number Publication Date
DK1856090T3 true DK1856090T3 (da) 2009-11-30

Family

ID=36694345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06720513T DK1856090T3 (da) 2005-02-11 2006-02-09 Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser

Country Status (25)

Country Link
US (1) US8084489B2 (fr)
EP (1) EP1856090B1 (fr)
JP (1) JP4988604B2 (fr)
KR (1) KR20070104409A (fr)
CN (1) CN101115735B (fr)
AT (1) ATE445609T1 (fr)
AU (1) AU2006213894B2 (fr)
BR (1) BRPI0607015A2 (fr)
CA (1) CA2597073C (fr)
CR (1) CR9304A (fr)
CY (1) CY1109624T1 (fr)
DE (1) DE602006009773D1 (fr)
DK (1) DK1856090T3 (fr)
EA (1) EA200701705A1 (fr)
ES (1) ES2332470T3 (fr)
IL (1) IL184932A0 (fr)
MA (1) MA29432B1 (fr)
MX (1) MX2007009661A (fr)
NO (1) NO20074567L (fr)
PL (1) PL1856090T3 (fr)
PT (1) PT1856090E (fr)
SI (1) SI1856090T1 (fr)
TN (1) TNSN07313A1 (fr)
WO (1) WO2006086488A2 (fr)
ZA (1) ZA200706354B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE455756T1 (de) * 2004-06-14 2010-02-15 Lilly Co Eli Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
ES2720430T3 (es) 2007-02-09 2019-07-22 Metabasis Therapeutics Inc Antagonistas novedosos del receptor de glucagón
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
ES2527670T3 (es) 2008-08-13 2015-01-28 Metabasis Therapeutics, Inc. Antagonistas de glucagón
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2582709B1 (fr) 2010-06-18 2018-01-24 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
AU2011346670B2 (en) 2010-12-23 2015-05-07 Pfizer Inc. Glucagon receptor modulators
ME02502B (fr) 2011-02-08 2017-02-20 Pfizer Modulateur du récepteur de glucagon
WO2012120056A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (fr) 2011-03-08 2016-06-01 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
EP2683699B1 (fr) 2011-03-08 2015-06-24 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
RU2013157388A (ru) 2011-07-22 2015-08-27 Пфайзер Инк. Хинолинильные модуляторы глюкагонового рецептора
EP2567959B1 (fr) 2011-09-12 2014-04-16 Sanofi Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr) 2011-09-27 2013-04-04 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
TW201427658A (zh) 2012-12-10 2014-07-16 Merck Sharp & Dohme 藉由投予升糖素受體拮抗劑及膽固醇吸收抑制劑治療糖尿病之方法
WO2015066252A1 (fr) 2013-11-04 2015-05-07 Merck Sharp & Dohme Corp. Composés antagonistes du récepteur du glucagon, compositions correspodantes et méthodes d'utilisation
WO2015191900A1 (fr) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Antagonistes du glucagon
US10829519B2 (en) 2015-09-18 2020-11-10 Wake Forest University Health Sciences Angiotensin (1-7) analogs and methods relating thereto
CA2914601A1 (fr) * 2015-12-11 2017-06-11 Wake Forest University Health Sciences Analogues d'angiotensine-(1-7) et methodes associees
EP3506940A1 (fr) 2016-08-30 2019-07-10 Regeneron Pharmaceuticals, Inc. Procédés de traitement de la résistance à l'insuline grave par interférence avec la signalisation du récepteur du glucagon
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
EP3672620A1 (fr) 2017-08-22 2020-07-01 Regeneron Pharmaceuticals, Inc. Méthodes de traitement des troubles liés au cycle de l'urée par interférence avec la signalisation du récepteur du glucagon
EP3752249A1 (fr) 2018-02-13 2020-12-23 Ligand Pharmaceuticals, Inc. Antagonistes de récepteur de glucagon
CN118496197A (zh) 2019-12-20 2024-08-16 拜耳公司 取代的噻吩甲酰胺、噻吩甲酸及其衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1463715A1 (fr) * 2001-12-03 2004-10-06 Novo Nordisk A/S Nouveaux antagonistes de glucagon
AU2003233780A1 (en) 2002-06-27 2004-01-19 Novo Nordisk A/S Novel glucagon antagonists/inverse agonists
US7989457B2 (en) * 2004-05-28 2011-08-02 Eli Lilly And Company Glucagon receptor antagonists, preparation and therapeutic uses
ATE455756T1 (de) * 2004-06-14 2010-02-15 Lilly Co Eli Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung

Also Published As

Publication number Publication date
AU2006213894B2 (en) 2011-12-08
ES2332470T3 (es) 2010-02-05
CR9304A (es) 2008-03-31
WO2006086488A3 (fr) 2006-12-14
ZA200706354B (en) 2008-11-26
CN101115735A (zh) 2008-01-30
US8084489B2 (en) 2011-12-27
JP4988604B2 (ja) 2012-08-01
EA200701705A1 (ru) 2008-02-28
KR20070104409A (ko) 2007-10-25
AU2006213894A1 (en) 2006-08-17
CA2597073A1 (fr) 2006-08-17
EP1856090A2 (fr) 2007-11-21
EP1856090B1 (fr) 2009-10-14
SI1856090T1 (sl) 2010-02-26
MX2007009661A (es) 2007-09-25
CN101115735B (zh) 2013-01-09
MA29432B1 (fr) 2008-05-02
PT1856090E (pt) 2009-11-18
TNSN07313A1 (en) 2008-12-31
DE602006009773D1 (de) 2009-11-26
JP2008530102A (ja) 2008-08-07
PL1856090T3 (pl) 2010-02-26
NO20074567L (no) 2007-11-08
BRPI0607015A2 (pt) 2009-12-01
ATE445609T1 (de) 2009-10-15
IL184932A0 (en) 2007-12-03
WO2006086488A2 (fr) 2006-08-17
CY1109624T1 (el) 2014-08-13
US20100137417A1 (en) 2010-06-03
CA2597073C (fr) 2014-11-25

Similar Documents

Publication Publication Date Title
DK1856090T3 (da) Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser
DK1957484T3 (da) Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser
NO20070213L (no) Glucagon reseptorantagonister, fremstilling og terapeutiske anvendelser
WO2007106181A3 (fr) Antagonistes des récepteurs du glucagon, leur préparation et leurs utilisations thérapeutiques
WO2007120270A3 (fr) Antagonistes de récepteur du glucagon, procédés de préparation et utilisations thérapeutiques
DK1951659T3 (da) Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf
DK1735278T3 (da) Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης